Can Harmony Biosciences (HRMY) Climb 25.05% to Reach the Level Wall Street Analysts Expect?

Harmony Biosciences Holdings, Inc. (HRMY) closed the last trading session at $35.09, gaining 1.1% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of$ 43.88 indicates a 25.1% upside potential. The average comprises eight short-term price targets ranging from a low of $28 to a high of$ 56, with a standard deviation of $10.20. While the lowest estimate indicates a decline of 20.2% from t ...